UK’s largest drugmaker has been rocked by detention of its China business head

Benzinga

New York

United States

AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investigations 'Very Seriously' - AstraZeneca (NASDAQ:AZN)

The group’s shares have tumbled after it emerged that the firm’s China president has been detained as Chinese authorities deepen their investigation.

Ad Fontes Media

All Sides

Media Bias/Fact Check

The Independent

Evgeny Lebedev

London

Greater London

England

United Kingdom

AstraZeneca boss says firm takes China probe ‘very seriously’

President of Chinese division is accused of illegally importing cancer drugs

The Telegraph

Press Holdings

David and Frederick Barclay

AstraZeneca chief taking arrest of Chinese executive ‘very seriously’

AstraZeneca reports $13.57 billion in Q3 sales, up 18% year-over-year. Announces $3.5B U.S. investment to boost R&D and manufacturing with 1,000 new jobs.

British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and drug imports by the group that led to the detention of its China boss. 

"We take the matters in China very seriously," chief executive Pascal Soriot said in a statement contained in the group's latest earnings release. 

"If requested we will fully cooperate with the authorities. We remain committed

WION

Invesco

Noida

Uttar Pradesh

India

Pharma giant AstraZeneca takes China probes 'very seriously'

British pharmaceutical giant AstraZeneca on Tuesday said it takes "very seriously" China's investigations into potential illegal data collection and d

ABS-CBN

Lopez Group of Companies

Quezon City

Metro Manila

Philippines

Astrachef: Kinaanklagelse tas ”på stort allvar”

Dagens Nyheter.

Bonnier Group

Stockholm

Stockholm County

Sweden

Astra chief: China accusation is taken "very seriously"

Financial Times

Nikkei Inc.

AstraZeneca chief says pharma group takes China probe ‘very seriously’

12:49 Pascal Soriot, CEO of AstraZeneca, stresses that the British pharmaceutical company takes the Chinese investigation into alleged illegal imports of medicines "very seriously". At the same time, the pharmaceutical giant is again withdrawing its...

12:49 Pascal Soriot, de CEO van AstraZeneca, benadrukt dat het Britse farmabedrijf het Chinese onderzoek naar vermeende illegale medicijninvoer 'zeer ernstig neemt'. De farmareus trekt tegelijk opnieuw zijn...

CEO farmareus AstraZeneca: 'We nemen onderzoek naar illegale medicijneninvoer in China zeer serieus'

De Tijd

Belgium

CEO of pharmaceutical giant AstraZeneca: 'We take investigations into illegal drug imports into China very seriously'

Explore more offers.Standard DigitalEssential digital access to quality FT journalism on any device. Pay a year upfront and save 20%.Global news & analysisExpert opinionFT App on Android & iOSFT Edit appFirstFT: the day's biggest stories20+ curated newslettersFollow topics & set alerts with myFTFT Videos & Podcasts10 monthly gift articles to share$75 per monthComplete digital access to quality FT journalism with expert analysis from industry lea…

Jingletree

AstraZeneca chief says group takes China probe ‘very seriously’

British pharmaceutical giant AstraZeneca on Tuesday said it takes “very seriously” China’s investigations into potential illegal data collection and drug imports by the group that led to the detention of its China boss. “We take the matters in China very seriously,” chief executive Pascal Soriot said in a statement contained in the group’s latest earnings […] The post Pharma giant AstraZeneca takes China probes ‘very seriously’ appeared first on…

AstraZeneca chief says pharma group takes China probe ‘very seriously’

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics